Alder Biopharmaceuticals Inc. (ALDR)

Oncology Corporate Profile

Stock Performance

11.9000
0.4000

HQ Location

11804 North Creek Parkway South
Bothell, WA 98011

Company Description

Alder Biopharmaceuticals Inc. uniquely identifies, develops and manufactures novel antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular and autoimmune and inflammatory disease areas. Alder's management team combines decades of industry experience with a proven track record for identifying and developing novel antibody therapeutics and enabling partners through the out-licensing of its technologies.

Website: http://www.alderbio.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
BMS-945429 (formerly ALD518)interleukin-6 monoclonal antibodySupportive CareIIBristol-Myers Squibb

View additional information on product candidates here »

Source: http://www.alderbio.com/

Recent News Headlines

7/25/2017 12:18 am

7/25/2017 12:18 am

7/25/2017 12:18 am

7/25/2017 12:18 am

7/25/2017 12:18 am

7/24/2017 06:17 am

7/24/2017 06:17 am

7/24/2017 06:17 am

7/24/2017 06:17 am

7/24/2017 06:17 am

7/18/2017 06:17 am

7/18/2017 06:17 am

7/18/2017 06:17 am

7/18/2017 06:17 am

7/13/2017 06:17 pm

7/13/2017 12:17 pm

7/13/2017 06:17 am

7/13/2017 06:17 am

7/12/2017 12:17 pm

7/12/2017 06:17 am

7/12/2017 06:17 am

7/12/2017 06:17 am

7/12/2017 06:17 am

7/12/2017 06:17 am

7/11/2017 12:17 pm